Drugs / buprenorphine/naloxone
last change Feb 2015 re-read 2 minutes ago

buprenorphine/naloxone

Developed for
opiate dependence
Investigated by
Alkermes, Inc. · Paolo Mannelli

Trials 1 · a red edge is where a trial was stopped

201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01690546 Sep 2012 → Feb 2015 opiate dependence Paolo Mannelli Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as buprenorphine/naloxone ClinicalTrials.gov intervention name — accepted as the source's own label NCT01690546